Display options
Share it on

Addict Behav Rep. 2017 Sep 23;6:106-111. doi: 10.1016/j.abrep.2017.09.001. eCollection 2017 Dec.

Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness.

Addictive behaviors reports

Milad Parpouchi, Akm Moniruzzaman, Stefanie N Rezansoff, Angela Russolillo, Julian M Somers

Affiliations

  1. Somers Research Group, Faculty of Health Sciences, Simon Fraser University, Blusson Hall, Room 11300 - 8888 University Dr., Burnaby, British Columbia V5A 1S6, Canada.

PMID: 29450244 PMCID: PMC5800549 DOI: 10.1016/j.abrep.2017.09.001

Abstract

BACKGROUND: Methadone maintenance treatment (MMT) has important protective effects related to reduced illicit opioid use, infectious disease transmission, and overdose mortality. Adherence to MMT has not been examined among homeless people. We measured MMT adherence and reported relevant characteristics among homeless adults experiencing mental illness in Vancouver, British Columbia, Canada.

MATERIAL AND METHODS: Homeless adults living with mental illness who had received MMT prior to the baseline interview of the Vancouver At Home study (

RESULTS: Mean MMT MPR was 0.47. A large proportion of participants reported blood-borne infectious disease, three or more chronic physical health conditions, and substance use. Being single and never married was associated with significantly lower MMT MPR (0.40 vs. 0.55,

CONCLUSIONS: The level of adherence to MMT was very low among homeless adults experiencing mental illness. Efforts are needed to improve adherence to MMT as a means of reducing illicit substance use, preventing overdose deaths, and attenuating infectious disease transmission.

Keywords: Adherence; BC, British Columbia; Homeless; MMT, methadone maintenance treatment; MPR, medication possession ratio; MSP, Medical Services Plan; Medication possession ratio; Mental illness; Methadone; Opioid dependence; VAH, Vancouver At Home

References

  1. J Addict Med. 2017 Jan/Feb;11(1):28-33 - PubMed
  2. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209 - PubMed
  3. Schizophr Bull. 2017 Jul 1;43(4):852-861 - PubMed
  4. CMAJ. 2012 Apr 3;184(6):E317-28 - PubMed
  5. BMJ Open. 2012 Nov 22;2(6):null - PubMed
  6. JAMA Intern Med. 2013 Feb 11;173(3):189-95 - PubMed
  7. J Subst Abuse Treat. 2008 Sep;35(2):109-15 - PubMed
  8. Am J Public Health. 2010 Aug;100(8):1454-61 - PubMed
  9. J Gen Intern Med. 2007 Jul;22(7):1011-7 - PubMed
  10. N Engl J Med. 2009 Aug 20;361(8):777-86 - PubMed
  11. AIDS Behav. 2005 Sep;9(3):251-65 - PubMed
  12. CMAJ. 2004 Aug 3;171(3):235-9 - PubMed
  13. Harm Reduct J. 2013 Mar 06;10:3 - PubMed
  14. Med Care. 1988 Aug;26(8):814-23 - PubMed
  15. Ther Drug Monit. 2002 Aug;24(4):457-70 - PubMed
  16. J Addict Dis. 2012;31(3):270-7 - PubMed
  17. Soc Psychiatry Psychiatr Epidemiol. 2016 Dec;51(12 ):1623-1632 - PubMed
  18. Trials. 2013 Nov 01;14:365 - PubMed
  19. Addiction. 2005 Jul;100(7):981-9 - PubMed
  20. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145 - PubMed
  21. J Addict Dis. 2010 Jan;29(1):1-14 - PubMed
  22. Curr Pharm Des. 2014;20(25):4097-105 - PubMed
  23. PLoS One. 2017 Jan 11;12 (1):e0168745 - PubMed
  24. J Gen Intern Med. 2003 Nov;18(11):921-8 - PubMed
  25. MMWR Morb Mortal Wkly Rep. 2016 Jan 01;64(50-51):1378-82 - PubMed
  26. J Addict Med. 2016 Jan-Feb;10 (1):40-5 - PubMed
  27. BMC Psychiatry. 2015 Feb 26;15:32 - PubMed
  28. Lancet HIV. 2015 Oct;2(10 ):e445-50 - PubMed
  29. Drug Alcohol Depend. 2007 Jul 10;89(2-3):306-9 - PubMed
  30. J Prim Care Community Health. 2015 Jul;6(3):154-61 - PubMed

Publication Types